BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 25987700)

  • 21. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
    Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery.
    Kano H; Morales-Restrepo A; Iyer A; Weiner GM; Mousavi SH; Kirkwood JM; Tarhini AA; Flickinger JC; Lunsford LD
    J Neurosurg; 2018 Jan; 128(1):14-22. PubMed ID: 28106495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. External Validation of a Prognostic Score for Patients with Brain Metastases: Extended Diagnosis-Specific Graded Prognostic Assessment.
    Nieder C; Hess S; Lewitzki V
    Oncol Res Treat; 2020; 43(5):221-227. PubMed ID: 32213772
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative performances of prognostic indexes for breast cancer patients presenting with brain metastases.
    Braccini AL; Azria D; Thezenas S; Romieu G; Ferreri JM; Jacot W
    BMC Cancer; 2013 Feb; 13():70. PubMed ID: 23394467
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic indices in stereotactic radiotherapy of brain metastases of non-small cell lung cancer.
    Kaul D; Angelidis A; Budach V; Ghadjar P; Kufeld M; Badakhshi H
    Radiat Oncol; 2015 Nov; 10():244. PubMed ID: 26611493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of the Graded Prognostic Assessment (GPA) score in patients with brain metastases from primary tumours not represented in the diagnosis-specific GPA studies.
    Nieder C; Andratschke NH; Geinitz H; Grosu AL
    Strahlenther Onkol; 2012 Aug; 188(8):692-5. PubMed ID: 22526229
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined primary tumor and extracranial metastasis status as constituent factor of prognostic indices for predicting the overall survival in patients with brain metastases.
    Park YH; Kim TH; Jung SY; Kim YE; Bae JM; Kim YJ; Choi JH; Lee NK; Moon SH; Kim SS; Shin KH; Kim JY; Kim DY; Cho KH
    J Korean Med Sci; 2013 Feb; 28(2):205-12. PubMed ID: 23400308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).
    Sperduto PW; Yang TJ; Beal K; Pan H; Brown PD; Bangdiwala A; Shanley R; Yeh N; Gaspar LE; Braunstein S; Sneed P; Boyle J; Kirkpatrick JP; Mak KS; Shih HA; Engelman A; Roberge D; Arvold ND; Alexander B; Awad MM; Contessa J; Chiang V; Hardie J; Ma D; Lou E; Sperduto W; Mehta MP
    JAMA Oncol; 2017 Jun; 3(6):827-831. PubMed ID: 27892978
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).
    Sperduto PW; Jiang W; Brown PD; Braunstein S; Sneed P; Wattson DA; Shih HA; Bangdiwala A; Shanley R; Lockney NA; Beal K; Lou E; Amatruda T; Sperduto WA; Kirkpatrick JP; Yeh N; Gaspar LE; Molitoris JK; Masucci L; Roberge D; Yu J; Chiang V; Mehta M
    Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):812-816. PubMed ID: 29063850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic scores in brain metastases from breast cancer.
    Nieder C; Marienhagen K; Astner ST; Molls M
    BMC Cancer; 2009 Apr; 9():105. PubMed ID: 19351389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new grading system focusing on neurological outcomes for brain metastases treated with stereotactic radiosurgery: the modified Basic Score for Brain Metastases.
    Serizawa T; Higuchi Y; Nagano O; Matsuda S; Ono J; Saeki N; Hirai T; Miyakawa A; Shibamoto Y
    J Neurosurg; 2014 Dec; 121 Suppl():35-43. PubMed ID: 25434935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.
    Sperduto PW; Deegan BJ; Li J; Jethwa KR; Brown PD; Lockney N; Beal K; Rana NG; Attia A; Tseng CL; Sahgal A; Shanley R; Sperduto WA; Lou E; Zahra A; Buatti JM; Yu JB; Chiang V; Molitoris JK; Masucci L; Roberge D; Shi DD; Shih HA; Olson A; Kirkpatrick JP; Braunstein S; Sneed P; Mehta MP
    Neuro Oncol; 2018 Nov; 20(12):1652-1660. PubMed ID: 30418657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort.
    Janssen S; Hansen HC; Dziggel L; Schild SE; Rades D
    Radiol Oncol; 2019 May; 53(2):219-224. PubMed ID: 31103998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database.
    Sperduto PW; Berkey B; Gaspar LE; Mehta M; Curran W
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):510-4. PubMed ID: 17931798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA).
    Patrikidou A; Chaigneau L; Isambert N; Kitikidou K; Shanley R; Ray-Coquard I; Valentin T; Malivoir B; Laigre M; Bay JO; Moureau-Zabotto L; Bompas E; Piperno-Neumann S; Penel N; Alcindor T; Guillemet C; Duffaud F; Hügli A; Le Pechoux C; Dhermain F; Blay JY; Sperduto PW; Le Cesne A
    BMC Cancer; 2020 Feb; 20(1):117. PubMed ID: 32050939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic Factors and Survival Outcomes among Patients with Breast Cancer and Brain Metastases at Diagnosis: A National Cancer Database Analysis.
    Zimmerman BS; Seidman D; Cascetta KP; Ru M; Moshier E; Tiersten A
    Oncology; 2021; 99(5):280-291. PubMed ID: 33652435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients.
    Sperduto PW; Chao ST; Sneed PK; Luo X; Suh J; Roberge D; Bhatt A; Jensen AW; Brown PD; Shih H; Kirkpatrick J; Schwer A; Gaspar LE; Fiveash JB; Chiang V; Knisely J; Sperduto CM; Mehta M
    Int J Radiat Oncol Biol Phys; 2010 Jul; 77(3):655-61. PubMed ID: 19942357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Are prognostic indices for brain metastases of melanoma still valid in the stereotactic era?
    Badakhshi H; Engeling F; Budach V; Ghadjar P; Zschaeck S; Kaul D
    Radiat Oncol; 2018 Jan; 13(1):3. PubMed ID: 29316943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical resection of brain metastases: the prognostic value of the graded prognostic assessment score.
    Jakola AS; Gulati S; Nerland US; Solheim O
    J Neurooncol; 2011 Dec; 105(3):573-81. PubMed ID: 21660540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the new Graded Prognostic Assessment scale for brain metastases: a multicenter prospective study.
    Villà S; Weber DC; Moretones C; Mañes A; Combescure C; Jové J; Puyalto P; Cuadras P; Bruna J; Verger E; Balañà C; Graus F
    Radiat Oncol; 2011 Mar; 6():23. PubMed ID: 21366924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.